+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Kaposi Sarcoma Market 2021-2025- Product Image

Global Kaposi Sarcoma Market 2021-2025

  • ID: 5300867
  • Report
  • February 2021
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • ADVANZ PHARMA Corp. Ltd.
  • Aurobindo Pharma Ltd.
  • Baxter International Inc.
  • Bristol-Myers Squibb Co.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • MORE
Global Kaposi Sarcoma Market 2021-2025

The publisher has been monitoring the kaposi sarcoma market and it is poised to grow by $20.89 mn during 2021-2025 progressing at a CAGR of 3% during the forecast period. The report on kaposi sarcoma market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising number of organ transplants and rising number of HIV patients. In addition, rising number of organ transplants is anticipated to boost the growth of the market as well.

The kaposi sarcoma market analysis includes type segment and geographical landscapes.

The kaposi sarcoma market is segmented as below:

By Type
  • HAART
  • Chemotherapy
  • Immunotherapy
By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the increasing cancer prevalence in developing countries as one of the prime reasons driving the kaposi sarcoma market growth during the next few years.

Thereport on kaposi sarcoma market covers the following areas:
  • Kaposi sarcoma market sizing
  • Kaposi sarcoma market forecast
  • Kaposi sarcoma market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading kaposi sarcoma market vendors that include ADVANZ PHARMA Corp. Ltd., Aurobindo Pharma Ltd., Baxter International Inc., Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Galen Ltd., GlaxoSmithKline Plc, and Merck & Co. Inc.. Also, the kaposi sarcoma market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • ADVANZ PHARMA Corp. Ltd.
  • Aurobindo Pharma Ltd.
  • Baxter International Inc.
  • Bristol-Myers Squibb Co.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Treatment Type
  • Market segments
  • Comparison by treatment type
  • HAART - Market size and forecast 2020-2025
  • Chemotherapy - Market size and forecast 2020-2025
  • Immunotherapy - Market size and forecast 2020-2025
  • Market opportunity by treatment type
Customer landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • ADVANZ PHARMA Corp. Ltd.
  • Aurobindo Pharma Ltd.
  • Baxter International Inc.
  • Bristol-Myers Squibb Co.
  • Dr. Reddy’s Laboratories Ltd.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • Galen Ltd.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Other1 - Market share 2020-2025 (%)
  • Comparison by Other1
  • HAART - Market size and forecast 2020-2025 ($ million)
  • HAART - Year-over-year growth 2020-2025 (%)
  • Chemotherapy - Market size and forecast 2020-2025 ($ million)
  • Chemotherapy - Year-over-year growth 2020-2025 (%)
  • Immunotherapy - Market size and forecast 2020-2025 ($ million)
  • Immunotherapy - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Other1
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • ADVANZ PHARMA Corp. Ltd. - Overview
  • ADVANZ PHARMA Corp. Ltd. - Product and service
  • ADVANZ PHARMA Corp. Ltd. - Key offerings
  • ADVANZ PHARMA Corp. Ltd. - Key customers
  • ADVANZ PHARMA Corp. Ltd. - Segment focus
  • Aurobindo Pharma Ltd. - Overview
  • Aurobindo Pharma Ltd. - Business segments
  • Aurobindo Pharma Ltd. - Key offerings
  • Aurobindo Pharma Ltd. - Key customers
  • Aurobindo Pharma Ltd. - Segment focus
  • Baxter International Inc. - Overview
  • Baxter International Inc. - Business segments
  • Baxter International Inc. - Key offerings
  • Baxter International Inc. - Key customers
  • Baxter International Inc. - Segment focus
  • Bristol-Myers Squibb Co. - Overview
  • Bristol-Myers Squibb Co. - Product and service
  • Bristol-Myers Squibb Co. - Key offerings
  • Bristol-Myers Squibb Co. - Key customers
  • Bristol-Myers Squibb Co. - Segment focus
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Business segments
  • Eli Lilly and Co. - Key offerings
  • Eli Lilly and Co. - Key customers
  • Eli Lilly and Co. - Segment focus
  • F. Hoffmann-La Roche Ltd. - Overview
  • F. Hoffmann-La Roche Ltd. - Business segments
  • F. Hoffmann-La Roche Ltd. - Key offerings
  • F. Hoffmann-La Roche Ltd. - Key customers
  • F. Hoffmann-La Roche Ltd. - Segment focus
  • Galen Ltd. - Overview
  • Galen Ltd. - Product and service
  • Galen Ltd. - Key offerings
  • Galen Ltd. - Key customers
  • Galen Ltd. - Segment focus
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Key customers
  • GlaxoSmithKline Plc - Segment focus
  • Merck & Co. Inc. - Overview
  • Merck & Co. Inc. - Business segments
  • Merck & Co. Inc. - Key offerings
  • Merck & Co. Inc. - Key customers
  • Merck & Co. Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • ADVANZ PHARMA Corp. Ltd.
  • Aurobindo Pharma Ltd.
  • Baxter International Inc.
  • Bristol-Myers Squibb Co.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • MORE
The publisher recognizes the following companies as the key players in the global kaposi sarcoma market: ADVANZ PHARMA Corp. Ltd., Aurobindo Pharma Ltd., Baxter International Inc., Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Galen Ltd., GlaxoSmithKline Plc, and Merck & Co. Inc..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing cancer prevalence in developing countries.'

According to the report, one of the major drivers for this market is the rising number of organ transplants.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
4 of 5
  • ADVANZ PHARMA Corp. Ltd.
  • Aurobindo Pharma Ltd.
  • Baxter International Inc.
  • Bristol-Myers Squibb Co.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • Galen Ltd.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll